`
`U.S. PatentNo. 8,791,154 B2 (“’154Paten ”)
`
`YANNI et al, “The In Vitro and In Vivo Ocular Pharmacology of
`Olopatadine (AL-4943A), an Effective Anti—Allergic/Antihistaminic
`Agent,” Journal of Ocular Pharmacology and Therapeutics, Volume
`12, Number 4, 1996, pp. 389-400 (“Yanni”)
`
`---
`
`1001
`
`1004
`
`1005 U.S. Pat. No. 6,995,186 B2 (“Castillo”)
`
`U.S. Pat. Pub.No. 2011/0082145 A1 (“Schneider”)
`
`U.S. Pat. No. 5,641,805 (“Hayakawa”)
`
`Handbook ofPharmaceutical Excipients
`
`1013
`
`David B. Troy, Remington: The Science andPractice OfPharmacy,
`Philadelphia College of Pharmacy and Science 21 st Ed., 229, 856-866
`(2005)
`
`1014 Declaration of Dr. Laskar
`
`1015
`
`Argentum Pharm. LLC v. Alcon Research Ltd, IPR2016-00544,
`Paper 8 (PTAB July 18, 2016)
`
`Apotex, Inc. v. Alcon Research Ltd, IPR2016-01640, Paper 2 (PTAB
`
`Aug. 18, 2016)
`
`--------
`
`1006
`
`1007
`
`1012
`
`
`
`Alcon Research, Ltd v. Watson Labs. ,
`69 (November 18, 2016)
`
`l—15-cv—01 159 (D. Del.) Paper
`
`Abelson & Gomes, “Olopatadine 0.2% ophthalmic solution: the first
`ophthalmic
`antiallergy agent with once-daily dosing,” Expert
`Opinion on Drug Metabolism & Toxicology, 4:4, 453—461 (2008)
`
`PharmaceuticalCalculations, 13th Ed., Ansell, 2010
`
`US. Patent No. 6,770,675
`
`
`
`Argentum Pharm. LLC v. Alcon Research, Ltd,
`Paper 1 (PTAB Feb. 2, 2016)
`
`lPR2016—00544,
`
`Apotex, Inc. v. Alcon Research Ltd , IPR2016-01640, Paper 3 (PTAB
`Aug. 18, 2016)
`
`Apotex, Inc. v. Alcon Research Ltd , IPR2016-01640, Paper 8 (PTAB
`Oct. 5, 2016)
`
`Apotex, Inc. v. Alcon Research Ltd, IPR2016-01640, Paper 9 (PTAB
`Nov. 30,2016)
`
`Abelson & Loeffler, Conjunctival Allergen Challenge: Models in the
`Investigation ofOcular Allergy, Current Allergy and Asthma Reports
`3:363—368 (2003)
`
`Eiichi Uchio, Treatment of allergic conjunctivitis with olopatadine
`hydrochloride eye drops, Clinical Ophthalmology 2(3):525-531, 527-
`528 (2008)
`
`0.2%
`“Efficacy of Once-Daily Olopataa’ine
`al.,
`Abelson et
`Ophthalmic Solution Compared to Twice-Daily Olopatadine 0.1%
`Ophthalmic Solution for the Treatment of Ocular Itching Induced by
`Conjunctival Allergen Challenge,” Current Eye Research 32:1017-
`1022 (2007)
`
`
`
`Leonardi, et al., “The anti-allergic effects of a cromolyn sodium-
`chlorphenz'ramine
`combination compared to
`ketotz'fen
`in
`the
`conjunctival
`allergen
`challenge model,”
`European
`J.
`of
`Ophthalmology 13(2):128-133 (2003)
`
`1029
`
`U.S. Patent Publication No. 2008/0085922
`
`1030
`
`1031
`
`https://www.pazeodropscom/
`
`1032
`
`Orange Book entry for PAZEO®
`
`,
`
`Alcon Research, Ltd v. Watson Labs, 1—15-cv—01 159 (D. Del.) Paper
`155 (March 1, 2018)
`
`
`
`1033
`
`EP 0214779
`
`1034
`
`U.S. Pat. No. 4,871,865
`
`v
`
`1035
`
`EP 0235796
`
`1036
`
`U.S. Pat. No. 5,116,863
`
`1037
`
`CV of Dr. PaulLaskar
`
`1038
`
`Handbook of Chemistry and Physics 2006, 87th Ed.
`
`1039
`
`U. S. Publication No. 2004/0198828 (“Abelson”)
`
`1040
`
`Nandi et al., “NANDI et al., “Synergistic Effect of PEG-400 and
`CyclodeXtrin to Enhance Solubility of Progesterone,” AAPS
`PharmSciTech 2003; 4 (1), pp 1-5.”
`
`
`
`LOFTSSON et al.,
`
`“Cyclodextrins
`
`enhanced topical delivery of corticosteroids to the eye,” Acta Ophthamologica Scandinavica, 2002, pp. 144-150.
`
`in eye drop fonnulations:
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
